Delivery Order SPE2DB22D1202-SPE2DB24FVEH1
Award Date
6/20/24
Potential Completion Date
6/21/24
Potential Value
$5.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Ropivacaine 0.2% 400 mg/200 mL medication to the Defense Logistics Agency (DLA). The contract was awarded to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has a ceiling value of $7,571.30 and is a firm fixed-price delivery order. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through...
This federal contract award, valued at $1,730.17, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office Division. The contract is for the delivery of 4565221300 - Ropivacaine 0.2% 200 mg/100 ml, a pharmaceutical product, to support military treatment facilities and programs. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and does not have a set-aside designation. Amerisourcebergen, as a major...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,710.52, is for the delivery of 4565232398 - Ropivacaine 0.2% 200 mg/100 ml in 100 ml doses. This is a firm fixed price, delivery order contract with a completion date of July 25, 2024. The contract has no set-aside designation, indicating open competition. Amerisourcebergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,805.82 firm fixed-price delivery order contract is for the provision of 4564431836 ROPIVACAINE 0.2% 400 MG/200 ML 200ML, a medical product. The contract has an ultimate completion date of April 30, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,324.50, is for the delivery of Ropivacaine 0.2% 400 mg/200 ml medication. The contract has an ultimate completion date of January 9, 2024 and is a firm fixed-price Delivery Order. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The $1,883.24 firm-fixed-price delivery order is for the supply of 4565878585 - Ropivacaine 0.2% 400 mg/200 ml medication. The contract has a period of performance through September 20, 2024 and does not have a set-aside designation. Amerisourcebergen Drug Corp's Corporate Office division is the prime contractor for this award. This delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,513.30, is for the delivery of Ropivacaine 0.2% 400 mg/200 ml injectable medication. It is a firm fixed-price delivery order contract with a period of performance through July 2024. This contract award is not designated as a set-aside and represents open competition. AmerisourceBergen also holds a...
This contract award is for the delivery of 400 mg/200 mL vials of ropivacaine 0.2% solution, a local anesthetic medication, to the Defense Logistics Agency (DLA). The firm-fixed-price delivery order, valued at $3,873.51, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract has an ultimate completion date of October 27, 2023 and is not set aside for any specific business category. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award, valued at $2,785.18, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the delivery of 4564390458 ! ROPIVACAINE 0.2% 200 MG/100 ML 100ML, a pharmaceutical product. The contract does not have a set-aside designation and is a Firm Fixed Price Delivery Order. Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is a major supplier of pharmaceutical products and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4557598550 - Ropivacaine 0.2% 400 mg/200 ml 200 ml. The firm-fixed-price delivery order, valued at $1,382.37, was awarded on June 21, 2022 with a completion date of June 22, 2022. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which is a for-profit...